Taiwan Biomaterial Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2019
November 08, 2019 at 01:31 am IST
Share
Taiwan Biomaterial Co., Ltd. announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced sales was TWD 5.660 million compared to TWD 109,000 a year ago. Operating loss was TWD 15.998 million compared to TWD 18.450 million a year ago. Net loss was TWD 15.282 million compared to TWD 16.276 million a year ago. Basic loss per share was TWD 0.46 compared to TWD 0.54 a year ago. For the nine months, sales was TWD 9.215 million compared to TWD 925,000 a year ago. Operating loss was TWD 55.336 million compared to TWD 51.259 million a year ago. Net loss was TWD 53.786 million compared to TWD 43.600 million a year ago. Basic loss per share was TWD 1.72 compared to TWD 1.45 a year ago.
Taiwan Biomaterial Co., Ltd. is a Taiwan-based company mainly engaged in provision of medical equipment. The products are still in research and development stage. The Company's subsidiary TAIWAN MEDICAL RAPID PROTOTYPING CO., LTD.(TRP) is engaged in trial production of medical equipment. Main products include foam artificial meninges products, stroke thrombus aspiration catheter products, repair and regeneration products for early degenerative arthritis and others.
TAIWAN BIOMATERIAL CO., LTD. 
